Quentin Van Thillo/LinkedIn
May 22, 2026, 00:40
Quentin Van Thillo: UZ Leuven Is Recognized as an HHT Center of Excellence
Quentin Van Thillo, Haematologist at UZ Leuven, shared on LinkedIn:
”The international patient organisation Cure HHT recognised UZ Leuven as an HHT Center of Excellence.
Many thanks to all the Leuven colleagues who made this possible!
Looking forward to collaborating with our international partners to further advance the research and care for HHT patients.”

Stay updated with Hemostasis Today.
-
Nov 21, 2026, 15:30Amin Marashi: How Does the Microbiome Trigger the Immune System to Suddenly Turn Against the Body’s Own Blood-Clotting Regulators?
-
Nov 21, 2026, 15:26Christina P.: Exploring Joint Involvement and Musculoskeletal Symptoms in Antiphospholipid Syndrome
-
Nov 21, 2026, 14:4410 Posts Not to Miss This Week
-
Nov 21, 2026, 14:21Two Emerging Mechanisms Linking Sickle Cell Disease to Thrombosis
-
Nov 21, 2026, 13:06Christine Faressa: Precision PRP and Platelet Biology in Musculoskeletal Care
-
Nov 21, 2026, 13:04Eyad Jamileh: Atrial Fibrillation – Bridging the Global Gaps in Diagnosis and Stroke Prevention
-
Nov 21, 2026, 12:49Thibault Veyron: Optimizing Bivalirudin Treatment in HIT
-
Nov 21, 2026, 12:44Paulus Kirchhof: Left Atrial Appendage Occlusion vs DOACs
-
Nov 21, 2026, 12:19Jiyeon Kim: Human Platelet Lysate – Advancing Cell Therapy and Space Research